Product Information
ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $637.9487 per EA under NDC 82009014422. Its NADAC has been published 28 times since Dec 17, 2025.
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009014422
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Biologic (BLA)
FDA Application
BLA761058On Market Since
4/30/2024
Price Statistics
The NADAC for ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML has been published 28 times since Dec 17, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $637.9487 per EA |
|---|---|
| All-time high | $637.9487 (Jun 24, 2026) |
| All-time low | $636.0367 (Dec 17, 2025) |
| 52-week high | $637.9487 |
| 52-week low | $636.0367 |
| Median price | $636.2231 |
| Average price | $636.4993 |
| Largest weekly change | +0.1% (May 20, 2026) |
| Weeks tracked | 28 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML?
The current National Average Drug Acquisition Cost (NADAC) for ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML, manufactured by Quallent Pharmaceuticals Health LLC, is $637.9487 per EA (NDC 82009014422), effective Jun 24, 2026.
How has the price of ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML changed over time?
Over the history we have for it, the NADAC for ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML has held within roughly two percent of its current level. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML?
Since Dec 17, 2025, the NADAC for ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML has ranged from a low of $636.0367 (Dec 17, 2025) to a high of $637.9487 (Jun 24, 2026), with a median of $636.2231 per EA.
Are there cheaper alternatives to ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML, but none are currently priced below it.
Who manufactures ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML?
ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML (NDC 82009014422) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification